|
Lymphomation.org
> About Lymphoma
Last update: 04/30/2008
|
 | The Big Picture: Battling the Hematological Malignancies: The 200 Years' War
Full article http://theoncologist.alphamedpress.org/cgi/content/full/13/2/126
PDF
... These challenges will be gradually overcome, if we (a) develop new
models of cooperation among academia, industry, and government
[and patients], (b) continue the growth of international participation in cancer research
(more keen minds to the task), and (c) convince the governments of the
world, including that of the U.S., that an investment in minimizing
the effects of cancer is as important as defending against other threats to the welfare and longevity of their citizens.
|
|
What is Lymphoma:
About
Cancer
Lymphoma is a cancer
affecting immune cells called lymphocytes
About
Lymphoma
- General
Where
Lymphoma Develops
Type
and Developmental Stages determines lymphoma type
Characteristics of Non-Hodgkin's
Lymphomas
Cell type
Histology
Grading
Staging
WHO
& REAL
classifications (two ways to evaluate and group types of NHL)
Host/tumor
interactions - the microenvironment
|
Background Topics:
|
|
|
Expert
Review Articles and Interviews
|
Sources
NHL Update 2007 .pdf
|
New: Jonathan
Friedberg,
MD
Hematologist, James P. Wilmot Cancer Center
University of Rochester Medical Center
Zeroing in on follicular Lymphoma
Web cast: patientpower
Funded by Andrew Schorr's Patient Power
www.patientpower.info/specialeditionlymphoma.asp
|
New: James Armitage,
M.D.
Joe Shapiro Professor of Medicine in the Oncology/Hematology Section
University of Nebraska Medical Center
Lymphomas Web cast: patientpower
|
Press, Oliver, MD
|
Latest Discoveries in NHL:
Update from the American Society of Hematology (ASH) Annual
Meeting
LLS (12/14/06)
|
|
Nichols, Craig R., MD
|
NHL from A to Z: A Guide for the Newly Diagnosed
LLS
PDF
|
Russell Schilder, MD, Stephanie Gregory, M.D., Stephen Schuster,
MD
|
Radioimmunotherapy of non-Hodgkin’s lymphomas
Healthology
(March 2006)
|
|
Leonard, John, MD
|
Advances in the Treatment of NHL: The Experts' Perspective
(Current Updates on Targeted Therapies)
LLS (10/19/05)
|
|
Making Decisions about Treatment for NHL
LLS
PDF (8/9/05)
|
|
Treatment
for the Older Non-Hodgkin Lymphoma Patient
LLS PDF (10/19/04)
|
|
Treatment Options in Relapsed, Indolent Non-Hodgkin's Lymphoma
Healthology
(2007)
|
|
Understanding Your Treatment Options for NHL
LLS
PDF (08/16/06)
|
|
|
|
Cheson, Bruce, MD
|
Looking Ahead: Novel Therapies in NHL Update from the
American Society of Hematology (ASH) Annual Meeting
LLS
PDF (12/13/05)
|
|
North American Education Forum on Lymphoma: Review of New
Agents
LRF
(Nov 2004)
|
|
|
|
Individualizing Therapy for the Hematologic Malignancies: The
Stuff of Genes and Dreams
jco.ascopubs.org
|
Fredrick Hagemeister, Jr, MD
Ronald Levy MD, David Fisher MD
|
Testing Vaccines for Non-Hodgkin's Lymphoma
Healthology
(Nov 2003)
|
|
John Hainsworth, MD, Sandra Horning MD, John Leonard MD
John Leonard, MD and Hillard Lazarus, MD
|
Lymphoma Update from the American Society of Hematology (ASH)
48th Annual Meeting
LLS PDF (Jan 2007)
|
|
John Hainsworth MD, John Leonard MD
Alexandra M. Levine, MD Robert S. Mocharnuk,
MD
|
Rituximab, Tositumomab, Ibritumomab: And the Winner Is...
Medscape
(free login req.)
|
|
David
G. Maloney, MD, PhD, Fred Hutchinson Cancer Research Center
| Developments in the Treatment of Follicular Non-Hodgkin’s
Lymphoma (NHL)
Update from ASCO 2006 and ASH 2005
ufscc.ufl.edu
|
|
|
|
Kieron Dunleavy, MD; Wyndham H. Wilson, MD, PHD
Epidemiology and Etiology
|
Lymphomas: Non-Hodgkin Lymphoma
From ACP Medicine Online
Posted 06/07/2006
Medscape (free
login req.)
|
|
Stephen M Ansell, MD, PHD, and
James Armitage, MD
|
Dr. Craig Nichols
|
NHL from A-Z: A Guide for the Newly Diagnosed
LLS
- PDF
|
|
Panel of Experts: A case-based discussion on the management
of non-Hodgkin’s lymphoma
For me, case discussions among experts (such as case3)
show why we should be a little uncomfortable with 'Let the Patient Decide' clinical practice. We need to hear the reasoning process of the experts we consult and make use of their educated clinical judgment.
|
Myron S Czuczman, MD comments on trials and different approaches to treating follicular lymphoma with intent to achieve durable remissions
nhlupdate.com
|
Dr.
John G. Gribben Institute of Cancer, Barts and The London, Queen
Mary School of Medicine, London, United Kingdom
|
Dr. Julie Vose on Treating Lymphomas
|
Dan L. Longo, MD, Scientific Director
National Institute on Aging Baltimore, Maryland
|
Dr. Zelenitz
|
